Science for Life

General Oncology is a biopharmaceutical company focused on first-in-class medicines in metastatic cancer, and has been committed to making a profound difference in cancer patients’ lives for over 30 years.

Our Approach

Through new and repurposed drugs, we endeavor to answer the fundamental question: how can we overcome drug resistance without causing significant patient toxicity?

Our Pipeline

Our clinical-stage candidate GO-4 is designed to treat BRCA-mutated cancers. Our extensive preclinical and discovery-phase pipeline is designed to treat other cancers and proliferative disorders.

Careers

General Oncology is poised for growth, providing career building tools and experiences. Join us in our mission to transform lives through science.

A 30-Year Mission

Since 1990, founding members of General Oncology have been engaged in extensive research focused on treatments for curing cancer while mitigating toxicity in patients.

Media & Press

Check out our press releases for the latest news.